UnitedHealth Group
UNH (NYSE)
UnitedHealth Group (UNH) stands out as a top US healthcare firm, boasting a strong 15% dividend growth rate over the past five years, making it a compelling choice for investors seeking stability and growing income. With a current dividend yield of approximately 2.18%, the company has delivered impressive returns, including a 38.43% gain over the past year. Analysts are optimistic, setting a median 12-month price target of $432.00, with a solid B+ rating reflecting confidence in its ongoing performance.
Pros:
- Strong 1-year return
- Diverse healthcare services
Cons:
- Lower dividend yield
- Market competition
UnitedHealth Group (UNH) presents a suitable investment opportunity for those seeking a blend of income stability and capital appreciation, particularly given its consistent dividend growth and strong recent performance. Investors looking for exposure to the healthcare sector, along with a reasonable dividend yield, may find UNH to be a compelling addition to their portfolios.